NPO Insider Filing: Phantom Stock Dividend Equivalents Increase Director Holdings
Rhea-AI Filing Summary
Ronald C. Keating, a director of EnPro Inc. (NPO), reported an accrual of dividend equivalent rights on phantom stock under the company's Deferred Compensation Plan for Non-Employee Directors that resulted in an acquisition reported on 09/17/2025. The entry shows phantom stock with an acquisition code and a reported price of $217.89, and the filing lists 3,773.5184 shares of common stock as beneficially owned following the transaction. The filing clarifies that these dividend equivalents relate to previously granted phantom stock, vest and pay out upon death, disability, or vesting/payout of the underlying award, and the balance reflects multiple grants and prior accruals.
Positive
- Reported increase in beneficial ownership to 3,773.5184 shares following accrual of dividend equivalent rights
- Clear disclosure that accruals relate to the Deferred Compensation Plan for Non-Employee Directors and include multiple grants
Negative
- None.
Insights
TL;DR: Routine director deferred compensation accrual increased reported beneficial ownership; no new cash exercise or sale activity disclosed.
The Form 4 documents that dividend equivalent rights accrued on previously granted phantom stock were recorded on 09/17/2025, increasing reported beneficial ownership to 3,773.5184 shares. This is a non-cash, plan-driven accrual under the Deferred Compensation Plan for Non-Employee Directors and vests or pays out only upon specific triggering events. From a governance perspective, the filing signals ongoing use of phantom stock for director compensation and does not indicate discretionary cash transactions or transfers of ownership.
TL;DR: The transaction is an administrative accrual of dividend equivalents on phantom shares, reflecting routine plan mechanics rather than a market-facing trade.
The disclosure identifies an acquisition entry for phantom stock dividend equivalents with a reported price of $217.89 and results in 3,773.5184 shares beneficially owned following the transaction. The explanations confirm these are dividend equivalent rights tied to earlier phantom grants and that payout timing depends on death, disability, or vesting/payout of the underlying awards. This is consistent with deferred director compensation practices and appears to aggregate multiple grants and accruals into the reported balance.